Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-01-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-024-00982-3 |
| _version_ | 1797350112141246464 |
|---|---|
| author | Yan-Yan Li Shuai-Shuai Ge Yuan-Hong Huang Ming-Zhu Xu Chao-Ling Wan Kai-Wen Tan Tao Tao Hai-Xia Zhou Sheng-Li Xue Hai-Ping Dai |
| author_facet | Yan-Yan Li Shuai-Shuai Ge Yuan-Hong Huang Ming-Zhu Xu Chao-Ling Wan Kai-Wen Tan Tao Tao Hai-Xia Zhou Sheng-Li Xue Hai-Ping Dai |
| author_sort | Yan-Yan Li |
| collection | DOAJ |
| first_indexed | 2024-03-08T12:40:07Z |
| format | Article |
| id | doaj.art-28a5249897d5441e98a9d67e6f83e339 |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-03-08T12:40:07Z |
| publishDate | 2024-01-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-28a5249897d5441e98a9d67e6f83e3392024-01-21T12:11:16ZengNature Publishing GroupBlood Cancer Journal2044-53852024-01-011411510.1038/s41408-024-00982-3Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot studyYan-Yan Li0Shuai-Shuai Ge1Yuan-Hong Huang2Ming-Zhu Xu3Chao-Ling Wan4Kai-Wen Tan5Tao Tao6Hai-Xia Zhou7Sheng-Li Xue8Hai-Ping Dai9National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityDepartment of Respiratory and Critical Medicine, The Affiliated Infectious Diseases Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow Universityhttps://doi.org/10.1038/s41408-024-00982-3 |
| spellingShingle | Yan-Yan Li Shuai-Shuai Ge Yuan-Hong Huang Ming-Zhu Xu Chao-Ling Wan Kai-Wen Tan Tao Tao Hai-Xia Zhou Sheng-Li Xue Hai-Ping Dai Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study Blood Cancer Journal |
| title | Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study |
| title_full | Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study |
| title_fullStr | Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study |
| title_full_unstemmed | Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study |
| title_short | Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study |
| title_sort | efficacy and safety of cladribine low dose cytarabine and venetoclax in relapsed refractory acute myeloid leukemia results of a pilot study |
| url | https://doi.org/10.1038/s41408-024-00982-3 |
| work_keys_str_mv | AT yanyanli efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT shuaishuaige efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT yuanhonghuang efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT mingzhuxu efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT chaolingwan efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT kaiwentan efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT taotao efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT haixiazhou efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT shenglixue efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy AT haipingdai efficacyandsafetyofcladribinelowdosecytarabineandvenetoclaxinrelapsedrefractoryacutemyeloidleukemiaresultsofapilotstudy |